SEC Form 4 · accession 0001209191-15-048176
AVEO PHARMACEUTICALS INC · AVEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith S Ehrlich
Officer — Chief Financial Officer
Period of report
May 5, 2015
Accepted (ET)
Jun 1, 2015 · 9:21 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.57 | May 5, 2015 | A | 400,000 | A | — | May 5, 2025 | Common Stock | 400,000 | 400,000 | D |
Explanation of responses
- F1This option will vest as to 25% of the shares on May 5, 2016, and in thirty-six monthly installments thereafter as to the remaining shares through May 5, 2019.